Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation

Tags:

Washington, D.C.

Date: November 15, 2019

Matter Number:

191 0061

Docket Number:

C-4690

By:

Rebecca Kelly Slaughter, Commissioner

application/pdf icon

Dissenting Statement of Commissioner Rebecca Kelly Slaughter In the Matter of Bristol-Myers Squibb Company and Celgene Corporation (40.74 KB)